It’s not a storm — it’s the climate

It’s not a storm — it’s the climate

26 March 2026

Roche: Here, There and Everywhere!

In this episode of Category Leaders, Colin Brown and Martti Wallin explore the fascinating history of Roche, a Swiss pharmaceutical giant, from its origins in the 1890s to its evolution into a leader in biotech and diagnostics. Discover how strategic capital reallocation, innovation, and navigating geopolitical risks shaped its journey and contributed to the development of modern medicine.

This episode explores Roche’s strategic evolution from a vitamins manufacturer to a biotech and precision medicine powerhouse. We analyse their innovative approach to diagnostics, biologics, and their system of scientific autonomy, governance, and process power that sustains their industry leadership.

TAKEAWAYS:

  • Historical evolution of Roche from 1890s to present
  • Strategic capital reallocation and innovation cycles
  • Impact of geopolitical risks on global expansion
  • Transition from vitamins to blockbuster drugs and biotech
  • Role of science and manufacturing integration Roche’s acquisition of Genentech and Chugai
  • The shift to biologics and precision oncology
  • Diagnostics as a core strategic asset
  • The role of governance and family control
  • Roche’s system of research, manufacturing, and diagnostics
  • The importance of process power and scale economics
  • Roche’s response to global market challenges, including China headwinds and COVID-19
  •